Integra LifeSciences Corporation
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Integra LifeSciences Corporation sits in the top decile of US sponsors by registered trial count (#336 of 15,742 sponsors by registered trial count).
Integra LifeSciences Corporation: 60 sponsored US clinical trials, 3 recruiting.
Integra LifeSciences Corporation sponsors 60 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 38 completed. 5 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Diabetic Foot Ulcer, with 2 trials.
Top-decile sponsor footprint
Integra LifeSciences Corporation ranks in the top decile of sponsors by registered trial count (#336 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
38 of 57 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (66.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
60 total, page 1 of 2
AERA Pediatrics Registry
NCT07071298
A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers
NCT06453187
The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation
NCT04494295
MicroMatrix® Flex in Tunneling Wounds
NCT06629506
Cavitronic Ultrasonic Surgical Aspiration (CUSA) Women's Health Study
NCT06297187
T-GENVIH-003 LTFU (Long Term Follow Up) Study
NCT06034652
Gentrix® Surgical Matrix for Soft Tissue Reinforcement in Ventral Hernia Repair
NCT05610267
REINVENT Registry (Registry of the Nerve Gap Repair From Integra)
NCT05339594
NeuraGen 3D Pilot Study
NCT05343143
The Purpose of This Study is to Determine Whether CerebroFlo™ EVD Catheter is Effective During the Treatment of Intraventricular Hemorrhage (IVH)
NCT05113381
Suturable DuraGen™ PMCF Study
NCT04923867
Diabetic Foot Ulcer Study Comparing Cytal Wound Matrix 1-Layer to Standard of Care
NCT03626623
Sundt™ Carotid Shunt Retrospective Post Market Clinical Follow-up Study (PMCF)
NCT03816202
The Management of Pilonidal Wounds With ACell MicroMatrix® and Cytal® Wound Matrix: A Case Series
NCT04041037
Cytal® Wound Matrix and MicroMatrix® Wound Study
NCT03632954
AMNIOEXCEL® Plus vs A Marketed Comparator vs SOC in the Management of Diabetic Foot Ulcers
NCT03547635
Comparing Concomitant Use of ACell MicroMatrix® and ACell Cytal™ to Standard of Care in Stage 3 or 4 Pressure Injuries
NCT03283787
PriMatrix for the Management of Diabetic Foot Ulcers
NCT03010319
Open-Label Study in Diabetic Foot Ulcers (DFU), to Evaluate Safety of 0.03% DSC127 Topical Gel in Chronic Use
NCT01840085
MEDIHONEY® Gel Versus Collagenase for Wound Debridement
NCT02482948
Global Sinus Surgery Registry
NCT02347943
Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers
NCT02209051
ACell MatriStem Pelvic Floor Matrix Versus Native Tissue Repair, Comparative Study
NCT02021279
Study of Safety and Efficacy for the Eustachian Tube Balloon Catheter
NCT02087150
Retrospective Study Evaluating Outcomes for Integra® Skin Sheet Products in Lower Extremity Complex Wounds
NCT01947387
A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers
NCT01858545
Phase 3 Study Evaluating Efficacy and Safety of DSC127 Compared With Vehicle and With Standard-of-care in Diabetic Foot Ulcers
NCT01849965
Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers
NCT01830348
Comparison of Balloon Sinuplasty In-Office Versus Medical Management for Recurrent Acute Sinusitis Patients (CABERNET)
NCT01714687
Medical Therapy Versus Balloon Sinus Dilation for Patients With Chronic Rhinosinusitis
NCT01685229
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
NCT01729286
Earset Healthy Volunteer Study
NCT01611246
Tympanostomy Tube Placement in Children in the Office (Inova Study)
NCT01496287
inVENT-visIOn Study
NCT01444391
DuraSeal Exact Spine Sealant System Post-Approval Study
NCT01410864
Healthy Volunteer Study
NCT01346332
inVENT-In-Office Study
NCT01324271
A Study With Primatrix Dermal Repair Scaffold For The Treatment Of Diabetic Foot Ulcers
NCT01270633
Evaluation of the Tympanostomy Tube Delivery System
NCT01202578
A Multicenter, Prospective, Observational Study With PriMatrix for the Treatment of Neuropathic Diabetic Foot Ulcers
NCT01228526
Optimization and Refinement of Technique in In-Office Sinus Dilation 2
NCT01107379
A Safety and Efficacy Study of INTEGRA® Dermal Regeneration Template for the Treatment of Diabetic Foot Ulcers
NCT01060670
Acclarent Tympanostomy Tube Delivery System for the Treatment of Patients Requiring Tympanostomy Tube Insertion
NCT02150044
An Evaluation of SprayShield in Reducing Post-Operative Adhesion Formation Following Major Open Abdominal Surgery
NCT01002287
Anesthetizing the Tympanic Membrane in Healthy Volunteers
NCT01047904
Large Abdominal Hernia Repair With SurgiMend 3.0
NCT00892333
Clinical Study of the Tympanostomy Tube Delivery System
NCT00939796
Clinical Study of Safety and Efficacy for the Relieva Stratus With Elution of Triamcinolone Acetonide
NCT00791934
PleuraSeal Pivotal Study (US)
NCT00748124
Balloon Sinus Dilation In Office or OR
NCT00939393
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 4 |
| Phase 4 | 1 |
Therapeutic Areas
Where Integra LifeSciences Corporation enrollment is open (later-stage tilt)
3 recruiting of 60 indexed (5% open); 38 completed (63%).
Phase mix: 5 late (III/IV) vs 1 early (I/II) (later-stage heavy).
Top condition: Diabetic Foot Ulcer (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Integra LifeSciences Corporation: open-pipeline peers nationwide
Peers matched on 60 registered trials and 5% open enrollment, not the therapeutic-area sidebar.
Integra LifeSciences Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 60 trials (± recruiting share)
- Henry M. Jackson Foundation for the Advancement of Military Medicine · 60 trials · 22% recruiting
- Endo USA Inc., a Keenova Therapeutics Company · 61 trials · 0% recruiting
- NICHD Neonatal Research Network · 61 trials · 7% recruiting
- Clinical Nutrition Research Center, Illinois Institute of Technology · 59 trials · 7% recruiting
Sponsors near 5% open enrollment (± trial volume)
- Avera McKennan Hospital & University Health Center · 5% recruiting · 20 trials
- HonorHealth Research Institute · 5% recruiting · 20 trials
- Lumenis Be · 5% recruiting · 20 trials
- Nathan Kline Institute for Psychiatric Research · 5% recruiting · 20 trials
Related
What to do with this Integra LifeSciences Corporation page
60 registered trials is a research-attention snapshot, not an endorsement of Integra LifeSciences Corporation or any single study.
- 3 of Integra LifeSciences Corporation's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Diabetic Foot Ulcer is the condition Integra LifeSciences Corporation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Diabetic Foot Ulcer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Integra LifeSciences Corporation pipeline card: 60 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.